Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

“Mark’s extensive financial, strategic, and operational expertise will be instrumental as we drive toward the submission and commercialization of cytisinicline, which if approved, will be the first new treatment for nicotine dependence in two decades,” said Rick Stewart, Chief Executive Officer of Achieve. “We look forward to welcoming him to our leadership team at such a critical time for Achieve and know his deep experience in public company biopharma leadership will make an immediate impact.” Read More

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer